Welcome to our dedicated page for Stratasys (ISRAEL) news (Ticker: SSYS), a resource for investors and traders seeking the latest updates and insights on Stratasys (ISRAEL) stock.
Stratasys Ltd. (NASDAQ: SSYS), headquartered in Minneapolis, Minnesota, and Rehovot, Israel, is a leading global provider of 3D printing and additive manufacturing solutions. Utilizing patented technologies such as FDM®, PolyJet®, and WDM™, Stratasys produces high-quality prototypes and manufactured goods directly from 3D CAD files or other 3D content.
Stratasys offers an array of 3D printers tailored for idea development, prototyping, and direct digital manufacturing. The company's subsidiaries include MakerBot and Solidscape, and it operates the RedEye digital-manufacturing service. Stratasys is an innovation leader, holding over 550 granted or pending additive manufacturing patents globally and has been awarded more than 25 accolades for its technological advancements and leadership.
Stratasys focuses primarily on polymer-based 3D printing solutions. These solutions cater to various sectors, including industrial, healthcare, and consumer fields. The company believes that polymer 3D printing solutions offer significant growth opportunities in the rapidly expanding 3D printing industry.
The company's comprehensive product line includes 3D printers such as FDM, PolyJet, Stereolithography, P3, and SAF. Additionally, Stratasys provides software solutions like GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software, which enhance the functionality and connectivity of their 3D printing systems.
Revenue generation for Stratasys comes from the sale of 3D printing systems, related services, and consumables, as well as providing comprehensive additive manufacturing solutions. With a workforce of over 1,900 employees, Stratasys continues to push the boundaries of what's possible in 3D printing.
Recent developments at Stratasys highlight the company's commitment to innovation and growth in the 3D printing landscape. Their latest news and updates reflect ongoing projects, new partnerships, and advancements in technology that keep them at the forefront of the industry.
Stratasys Ltd. (SSYS) reported a Q4 2021 revenue of $167 million, marking a 17.3% increase year-over-year. However, the company experienced a GAAP net loss of $4.8 million or $0.07 per diluted share. Non-GAAP net income stood at $0.5 million, reflecting a decline from previous figures. The company generated $4.4 million in cash from operations, ending the year with $502.2 million in cash and no debt. Looking ahead, Stratasys expects 2022 revenue between $680 million and $695 million with growth anticipated in the second half.
Stratasys (NASDAQ: SSYS) has collaborated with Radford to produce over 500 3D-printed parts for the Lotus Type 62-2 supercar, featured in the Discovery+ show Radford Returns. This partnership showcases the integration of advanced 3D printing technologies, such as FDM and PolyJet, in automotive manufacturing. The project exemplifies the shift towards customized manufacturing, allowing for unique vehicle designs with efficiency. The use of various Stratasys printers enabled Radford to achieve design freedom and meet the expectations of luxury vehicle aesthetics.
Stratasys announced a sponsorship for the
Stratasys emphasizes the importance of community support and aims to foster innovation in healthcare.
Stratasys Ltd (NASDAQ: SSYS) will announce its financial results for Q4 and full year 2021 on February 23, 2022 at 8:30 a.m. ET. A conference call will follow to discuss these results. Investors can access the call via a live webcast on the company’s investor relations website or by telephone at 877-407-0619 (U.S.) and +1-412-902-1012 (international). Stratasys is at the forefront of additive manufacturing, providing innovative 3D printing solutions across various industries including aerospace and healthcare, enhancing design and manufacturing agility.
MakerBot, a Stratasys company (NASDAQ: SSYS), is expanding its 3D printing materials with three new LUVOCOM® 3F products from LEHVOSS Group. This addition brings the total number of METHOD® materials to 30, enhancing options for engineering applications. The new materials feature high strength and heat resistance, suitable for prototyping and end-use parts. Notably, they provide enhanced performance characteristics, such as reduced warpage and excellent surface finish, improving the overall 3D printing experience.
Stratasys (NASDAQ: SSYS) will participate in the 24th Annual Needham Growth Conference from January 10–14, 2022. A fireside chat featuring CEO Dr. Yoav Zeif and incoming CFO Eitan Zamir will take place on January 13, 2022, at 12:30 p.m. ET. The event will be broadcast live and archived for 180 days, accessible at this link. Stratasys is recognized for its innovative 3D printing solutions across various industries, enhancing product design and manufacturing efficiency.
Stratasys Ltd. (NASDAQ: SSYS) announced the promotion of Eitan Zamir to chief financial officer, effective February 2022. Zamir, previously the vice president of finance, succeeds Lilach Payorski, who served nine years in the role. Zamir has proven financial expertise and has been integral in financial operations, reporting, and capital raising since joining Stratasys in 2019. CEO Dr. Yoav Zeif praised Zamir's leadership qualities, underscoring his alignment with the company’s growth strategy.
Stratasys has unveiled the Origin One Dental 3D printer, enhancing its offerings in the dental sector. This printer is designed for high accuracy and efficiency, capitalizing on the growing demand in the dental market, which is projected to reach $6.5 billion by 2025. Built on proprietary P3™ technology, it offers an open material infrastructure for diverse applications. This launch aligns with Stratasys' acquisition of Origin and complements their existing J5 DentaJet printer, together aiming to address the needs of modern dental labs.
Stratasys has launched the Digital Anatomy Creator software to enhance its Digital Anatomy 3D Printers, allowing healthcare providers to create patient-specific anatomic models more effectively. This software offers advanced customization options, enabling users to replicate human tissues accurately for diagnostic purposes and surgical preparation. Additionally, Stratasys collaborates with Synopsys and Materialise to integrate FDA 510(k)-cleared workflows in medical modeling, which facilitates point-of-care 3D printing. Healthcare providers can use this technology to improve surgical outcomes and reduce operational costs.
FAQ
What is the current stock price of Stratasys (ISRAEL) (SSYS)?
What is the market cap of Stratasys (ISRAEL) (SSYS)?
What does Stratasys Ltd. specialize in?
Where is Stratasys Ltd. headquartered?
What technologies does Stratasys use in its 3D printers?
What industries does Stratasys serve?
How does Stratasys generate revenue?
What are some subsidiaries of Stratasys Ltd.?
What software solutions does Stratasys offer?
How many employees does Stratasys have?
How many patents does Stratasys hold?
What recent achievements has Stratasys accomplished?
